Danaher Corporation (DHR)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$207.66-1.60%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · DHR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 5.2% |
| Our one-year growth estimate | diamond | 9.7% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 4.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 32 industry peers
DHR — capital allocation — CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALAN…
Dated 2026-06-03
CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT. Reference is made to the disclosure set forth under
Why it matters: This report will provide insights into revenue and profit trends. It is a key event for investors.
Watch forEarnings report shows better than expected revenue and EPS.
Also watch forEarnings report shows worse than expected revenue and EPS.
Why it matters: Details about the buyback program show management's trust in the company's value.
Supportive ifDanaher shares details about the share buyback program.
Worry ifNo announcement or further details on the share buyback program are made.
Why it matters: Details on the buyback program will show how Danaher uses capital. It shows value to shareholders.
Watch forThere will be an announcement about share repurchase volumes or plans.
Also watch forThere is no announcement or sign of share repurchase plans.
Why it matters: A good buyback program can support the stock price. It shows management's confidence. Poor execution may cause negative feelings.
Watch forThe stock price goes up after the buyback program is announced.
Also watch forStock price declines or remains flat despite the buyback announcement.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$128 on $10,000 · ±1.3% | How much price usually moves either way. |
| Bad day | $261 loss on $10,000 · 2.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,296 loss on $10,000 · 33.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Higher EPS guidance means stronger profit expectations. This can help investor confidence.
Supportive ifManagement raises EPS guidance for the next quarters.
Worry ifEPS guidance remains unchanged or is lowered.
Why it matters: This will show if Danaher can maintain growth momentum or if it is slowing down.
Worry ifQ3 non-GAAP core revenue growth below 2% year-over-year.
Less concerning ifQ3 non-GAAP core revenue growth of 2% or more year-over-year.
Why it matters: Higher EPS guidance means strong earnings growth and confidence from management.
Supportive ifAdjusted diluted EPS guidance raised to over $8.60 for 2026.
Worry ifGuidance for adjusted diluted EPS remains at or below $8.60.
Why it matters: Finishing this acquisition will show Danaher's skill in joining new businesses. It will help growth.
Supportive ifMasimo's purchase will be done by October 2026.
Worry ifMasimo's purchase is delayed or not done by October 2026.